← SynDRA
NELARABINE
SynDRA canonical compound SYN0023405 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | ADA | POLA1 |
| Mechanism of action | DNA synthesis inhibitor | T cell inhibitor |
| Indication | acute lymphoblastic leukemia (ALL) |
| Disease area | hematologic malignancy |
All known targets
Mechanisms of action (all sources)
- DNA synthesis inhibitor
- T cell inhibitor
Drug classes
- Nucleic Acid Synthesis Inhibitors
- Nucleoside Metabolic Inhibitor
ATC classes
Cross-references
Synonyms
- arranon
- nelzarabine
- atriance
- Nelarabina
- Attriance
- Nelzarabine
- 506U
- 506U78
- GW-506U78
- MAY
- NSC-686673
- NSC-755985
- NSC-759876
- Arranon
- Atriance
- ArranonG
- Nelarabine [USAN]
- Nelzarabine [USAN]
- GW506U78
- U78
- Arranon (GlaxoSmithKline)
- Arranon (TN)
- Arranon, Nelarabine
- Atriance (TN)
- GW-506U
- Nelarabine (INN)
- Nelzarabine (USAN)
- O-Methoxydeoxyguanosine
- O-Methylguanosine
- Nelarabine (JAN/USAN)
- (2R,3R,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- 2-(2-Amino-6-methoxy-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
- 2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- 2-Amino-6-methoxypurine arabinoside
- 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
- 6'-O-Methylguanosine
Look up NELARABINE in the interactive SynDRA portal →